SEC Filings

Filing date	Form	Description	View
05/03/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-055518.pdf 0001104659-23-055518.rtf 0001104659-23-055518.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
04/20/23	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001415889-23-006775.pdf 0001415889-23-006775.rtf 0001415889-23-006775.xls
04/18/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-006620.pdf 0001415889-23-006620.rtf 0001415889-23-006620.xls
04/17/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-045844.pdf 0001104659-23-045844.rtf 0001104659-23-045844.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
04/14/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-000113.pdf 0001950047-23-000113.rtf 0001950047-23-000113.xls
04/12/23	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	View HTML 0001193125-23-098992.pdf 0001193125-23-098992.rtf 0001193125-23-098992.xls
04/11/23	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-044043.pdf 0001104659-23-044043.rtf 0001104659-23-044043.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
04/11/23	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-044051.pdf 0001104659-23-044051.rtf
04/11/23	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001104659-23-044052.pdf 0001104659-23-044052.rtf 0001104659-23-044052.xls
03/28/23	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0001104659-23-037712.pdf 0001104659-23-037712.rtf 0001104659-23-037712.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.